Polymorphisms in Genes Involved in the Mechanism of Action of Methotrexate: Are They Associated with Outcome in Rheumatoid Arthritis Patients?

201440 citationsJournal Article

Authors

MTHFR, DHFR and ATIC genetic variants can be considered as pharmacogenetic markers of outcome in RA patients under MTX monotherapy.

Good health and well-being

Published in: Pharmacogenomics

Volume 15, Issue 8, pp. 1079-1090

Field-Weighted Citation Impact: 5.99